[{"Assets_0_Q2_USD":233143000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-52520000.0,"NetIncomeLoss_1_Q2_USD":-23018000.0,"NetIncomeLoss_2_Q2_USD":-44815000.0,"StockholdersEquity_0_Q2_USD":-64886000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]